206(top 1%)
PR articles
11.7K(top 1%)
PR citations
46(top 1%)
PR h-index
50(top 1%)
h-index
241
documents
15.2K
doc citations
3.4K
citing journals
100
times ranked

Publications

209 PR articles • 12,347 PR citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates6.310Citations (PDF)
2Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus
Cell Reports Medicine, 2024, 5, 101392
6.612Citations (PDF)
3Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic
Cell, 2024, 187, 5468-5482.e11
33.772Citations (PDF)
4Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study3.023Citations (PDF)
5A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus7.528Citations (PDF)
6The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens
Journal of Infectious Diseases, 2023, 228, S359-S375
3.819Citations (PDF)
7Ebola virus delta peptide is an enterotoxin
Cell Reports, 2022, 38, 110172
6.312Citations (PDF)
8Enterotoxigenic Escherichia coli Heat-Stable Toxin and Ebola Virus Delta Peptide: Similarities and Differences
Pathogens, 2022, 11, 170
3.03Citations (PDF)
9Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies
Cell Reports, 2022, 39, 110841
6.333Citations (PDF)
10Neutralizing Antibodies against Lassa Virus Lineage I
MBio, 2022, 13,
4.423Citations (PDF)
11The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
Science, 2022, 377, 960-966
36.2211Citations (PDF)
12The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
Science, 2022, 377, 951-959
36.2347Citations (PDF)
13Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model
Viruses, 2022, 14, 1741
3.215Citations (PDF)
14Lassa fever — the road ahead83.5140Citations (PDF)
15SARS-CoV-2 furin cleavage site was not engineered7.524Citations (PDF)
16Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades13.776Citations (PDF)
17Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus
Viruses, 2022, 14, 1993
3.215Citations (PDF)
18A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus12.530Citations (PDF)
19Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors3.014Citations (PDF)
20Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012–2019
Microorganisms, 2021, 9, 586
3.815Citations (PDF)
21A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
Immunity, 2021, 54, 815-828.e5
22.660Citations (PDF)
22Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone
Clinical Infectious Diseases, 2021, 73, 1046-1054
5.234Citations (PDF)
23Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail
Viruses, 2021, 13, 1202
3.234Citations (PDF)
24Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone
PLoS ONE, 2021, 16, e0252905
2.310Citations (PDF)
25Health seeking behavior after the 2013–16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone3.016Citations (PDF)
26The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response
Viruses, 2021, 13, 1605
3.213Citations (PDF)
27Ct Values Do Not Predict Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmissibility in College Students2.533Citations (PDF)
28Emergence of an early SARS-CoV-2 epidemic in the United States
Cell, 2021, 184, 4939-4952.e15
33.749Citations (PDF)
29The origins of SARS-CoV-2: A critical review
Cell, 2021, 184, 4848-4856
33.7444Citations (PDF)
30Zika Virus Non-Structural Protein 1 Antigen-Capture Immunoassay
Viruses, 2021, 13, 1771
3.27Citations (PDF)
31Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, 2021, 17, 1-382
13.72,296Citations (PDF)
32Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
Viruses, 2021, 13, 2325
3.236Citations (PDF)
33289. Post COVID Syndrome Cohort Characterization
Open Forum Infectious Diseases, 2021, 8, S251-S252
0.81Citations (PDF)
34Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
Emerging Infectious Diseases, 2020, 26, 2625-2637
3.823Citations (PDF)
35Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
Scientific Reports, 2020, 10,
3.423Citations (PDF)
36Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides3.629Citations (PDF)
37Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time13.7156Citations (PDF)
38Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
Journal of Infectious Diseases, 2020, 221, 156-161
3.843Citations (PDF)
39The proximal origin of SARS-CoV-2
Nature Medicine, 2020, 26, 450-452
33.04,280Citations (PDF)
40High crossreactivity of human T cell responses between Lassa virus lineages
PLoS Pathogens, 2020, 16, e1008352
4.431Citations (PDF)
41Proteomics Computational Analyses Suggest that the Envelope Glycoproteins of Segmented Jingmen Flavi-Like Viruses Are Class II Viral Fusion Proteins (β-Penetrenes) with Mucin-Like Domains
Viruses, 2020, 12, 260
3.226Citations (PDF)
42Identification of Common CD8+T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone3.624Citations (PDF)
43Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
Scientific Reports, 2020, 10,
3.429Citations (PDF)
44Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae
Journal of Infectious Diseases, 2020, 222, 1488-1497
3.817Citations (PDF)
45Ebola Mysteries and Conundrums
Journal of Infectious Diseases, 2019, 219, 511-513
3.80Citations (PDF)
46Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization
Cell, 2019, 178, 1004-1015.e14
33.752Citations (PDF)
47Antibody therapy for Lassa fever
Current Opinion in Virology, 2019, 37, 97-104
5.042Citations (PDF)
48Proteomics Computational Analyses Suggest that the Antennavirus Glycoprotein Complex Includes a Class I Viral Fusion Protein (α-Penetrene) with an Internal Zinc-Binding Domain and a Stable Signal Peptide
Viruses, 2019, 11, 750
3.210Citations (PDF)
492018 international meeting of the Global Virus Network
Antiviral Research, 2019, 163, 140-148
3.89Citations (PDF)
50Machine-learning Prognostic Models from the 2014–16 Ebola Outbreak: Data-harmonization Challenges, Validation Strategies, and mHealth Applications
EClinicalMedicine, 2019, 11, 54-64
8.247Citations (PDF)
51A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges
PLoS ONE, 2019, 14, e0214284
2.319Citations (PDF)
52Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever3.449Citations (PDF)
53Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
New England Journal of Medicine, 2018, 379, 1745-1753
34.6173Citations (PDF)
54Analysis of CD8 <sup>+</sup> T cell response during the 2013–2016 Ebola epidemic in West Africa7.564Citations (PDF)
55Annual Incidence of Lassa Virus Infection in Southern Mali0.020Citations (PDF)
56Virus genomes reveal factors that spread and sustained the Ebola epidemic
Nature, 2017, 544, 309-315
37.9417Citations (PDF)
57Genomic epidemiology reveals multiple introductions of Zika virus into the United States
Nature, 2017, 546, 401-405
37.9336Citations (PDF)
58Structural basis for antibody-mediated neutralization of Lassa virus
Science, 2017, 356, 923-928
36.2201Citations (PDF)
59Ebola Virus Delta Peptide Is a Viroporin3.641Citations (PDF)
60Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
Nature Medicine, 2017, 23, 1146-1149
33.0128Citations (PDF)
61Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers3.019Citations (PDF)
62Vectorborne Infections, Mali
Emerging Infectious Diseases, 2016, 22, 340-342
3.825Citations (PDF)
63Ebola Virus Epidemiology and Evolution in Nigeria
Journal of Infectious Diseases, 2016, 214, S102-S109
3.827Citations (PDF)
64Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits13.7172Citations (PDF)
65Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV8.878Citations (PDF)
66Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
Antiviral Research, 2016, 133, 218-222
3.867Citations (PDF)
67Epidemiology and Management of the 2013–16 West African Ebola Outbreak
Annual Review of Virology, 2016, 3, 147-171
7.531Citations (PDF)
68A Unified Framework for the Infection Dynamics of Zoonotic Spillover and Spread3.066Citations (PDF)
69IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System
PLoS ONE, 2015, 10, e0141655
2.313Citations (PDF)
70Current and Emerging Strategies for the Diagnosis, Prevention and Treatment of Lassa Fever
Future Virology, 2015, 10, 559-584
1.121Citations (PDF)
71Multiple Circulating Infections Can Mimic the Early Stages of Viral Hemorrhagic Fevers and Possible Human Exposure to Filoviruses in Sierra Leone Prior to the 2014 Outbreak
Viral Immunology, 2015, 28, 19-31
1.139Citations (PDF)
72Modeling of the Ebola Virus Delta Peptide Reveals a Potential Lytic Sequence Motif
Viruses, 2015, 7, 285-305
3.221Citations (PDF)
73Discovery of Novel Rhabdoviruses in the Blood of Healthy Individuals from West Africa3.070Citations (PDF)
74Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever3.0116Citations (PDF)
75Persistent Hepatitis C Virus Infection Impairs Ribavirin Antiviral Activity through Clathrin-Mediated Trafficking of Equilibrative Nucleoside Transporter 1
Journal of Virology, 2015, 89, 626-642
3.620Citations (PDF)
76Avian dark cells1.64Citations (PDF)
77Lassa Fever in Post-Conflict Sierra Leone3.0207Citations (PDF)
78Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples
Genome Biology, 2014, 15,
8.1141Citations (PDF)
79Inhibition of Arenavirus Infection by a Glycoprotein-Derived Peptide with a Novel Mechanism
Journal of Virology, 2014, 88, 8556-8564
3.615Citations (PDF)
80Unexpected Structural Features of the Hepatitis C Virus Envelope Protein 2 Ectodomain
Journal of Virology, 2014, 88, 10280-10288
3.637Citations (PDF)
81Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity2.2138Citations (PDF)
82Geographic Distribution and Genetic Characterization of Lassa Virus in Sub-Saharan Mali3.056Citations (PDF)
83A Fusion-Inhibiting Peptide against Rift Valley Fever Virus Inhibits Multiple, Diverse Viruses3.033Citations (PDF)
84Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
PLoS ONE, 2013, 8, e72791
2.315Citations (PDF)
85Mesenchymal stem cells as a novel vaccine platform4.127Citations (PDF)
86Topical vitamin A treatment of recalcitrant common warts
Virology Journal, 2012, 9,
3.617Citations (PDF)
87Release of Dengue Virus Genome Induced by a Peptide Inhibitor
PLoS ONE, 2012, 7, e50995
2.380Citations (PDF)
88Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report
Virology Journal, 2011, 8,
3.642Citations (PDF)
89Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1
Virology Journal, 2011, 8,
3.615Citations (PDF)
90Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report
Virology Journal, 2011, 8,
3.656Citations (PDF)
91Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines
Virology Journal, 2011, 8,
3.67Citations (PDF)
92Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection
Virology Journal, 2011, 8,
3.675Citations (PDF)
93Sequence similarity between the erythrocyte binding domain of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals a functional heparin binding motif involved in binding to the Duffy antigen receptor for chemokines
Virology Journal, 2011, 8,
3.66Citations (PDF)
94Peptide inhibition of human cytomegalovirus infection
Virology Journal, 2011, 8,
3.620Citations (PDF)
95The rate of hepatitis C virus infection initiation in vitro is directly related to particle density
Virology, 2010, 407, 110-119
2.317Citations (PDF)
96Detection of Lassa Virus, Mali
Emerging Infectious Diseases, 2010, 16, 1123-1126
3.8102Citations (PDF)
97Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone
Virology Journal, 2010, 7,
3.614Citations (PDF)
98Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
Virology Journal, 2010, 7,
3.614Citations (PDF)
99Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Virology Journal, 2010, 7,
3.687Citations (PDF)
100Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
Virology Journal, 2010, 7,
3.626Citations (PDF)
101Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway
Virology Journal, 2010, 7,
3.625Citations (PDF)
102Altered Immune Responses in Rhesus Macaques Co-Infected with SIV and Plasmodium cynomolgi: An Animal Model for Coincident AIDS and Relapsing Malaria
PLoS ONE, 2009, 4, e7139
2.318Citations (PDF)
103Proteomics computational analyses suggest that the bornavirus glycoprotein is a class III viral fusion protein (γ penetrene)
Virology Journal, 2009, 6, 145
3.615Citations (PDF)
104Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms
Virology Journal, 2009, 6, 147
3.616Citations (PDF)
105New opportunities for field research on the pathogenesis and treatment of Lassa fever
Antiviral Research, 2008, 78, 103-115
3.8168Citations (PDF)
106Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance
Virology Journal, 2008, 5, 74
3.625Citations (PDF)
107Alterations in intracellular potassium concentration by HIV-1 and SIV Nef
Virology Journal, 2008, 5, 60
3.611Citations (PDF)
108Proteomics computational analyses suggest that baculovirus GP64 superfamily proteins are class III penetrenes
Virology Journal, 2008, 5, 28
3.621Citations (PDF)
109Down-regulation of cell surface CXCR4 by HIV-1
Virology Journal, 2008, 5, 6
3.66Citations (PDF)
110Lassa Virus-Infected Rodents in Refugee Camps in Guinea: A Looming Threat to Public Health in a Politically Unstable Region2.118Citations (PDF)
111Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein
Virology Journal, 2007, 4, 123
3.637Citations (PDF)
112Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in Hepatitis C virus replicon
Virology Journal, 2007, 4,
3.621Citations (PDF)
113An invitation to recent graduates: Publish your dissertation/thesis background section as a review in Virology Journal
Virology Journal, 2007, 4, 46
3.60Citations (PDF)
114Aluminum Adjuvant Linked to Gulf War Illness Induces Motor Neuron Death in Mice
NeuroMolecular Medicine, 2007, 9, 83-100
3.696Citations (PDF)
115Role of Endogenous Retroviruses in Autoimmune Diseases3.227Citations (PDF)
116Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
Virus Research, 2006, 120, 146-155
2.671Citations (PDF)
117Musculoskeletal and autoimmune manifestations of HIV, syphilis and tuberculosis3.619Citations (PDF)
118Safe method for isolation of prion protein and diagnosis of Creutzfeldt–Jakob disease
Journal of Virological Methods, 2005, 130, 133-139
1.67Citations (PDF)
119Seroreactivity to A-type retrovirus proteins in a subset of cats with hyperthyroidism2.13Citations (PDF)
120Dengue in the Dominican Republic: Epidemiology for 20042.14Citations (PDF)
121Alterations of lymphocyte membranes during HIV-1 infection via multiple and simultaneous entry strategies2.13Citations (PDF)
122Of mice, cats, and men: Is human breast cancer a Zoonosis?2.136Citations (PDF)
123Human, rhesus macaque, and feline sequences highly similar to mouse mammary tumor virus sequences2.125Citations (PDF)
124Involvement of human intracisternal A-type retroviral particles in autoimmunity2.115Citations (PDF)
125Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein
Journal of Virology, 2005, 79, 7195-7206
3.6137Citations (PDF)
126Title is missing!
Virology Journal, 2005, 2, 49
3.6168Citations (PDF)
127The Aromatic Domain of the Coronavirus Class I Viral Fusion Protein Induces Membrane Permeabilization:  Putative Role during Viral Entry†
Biochemistry, 2005, 44, 947-958
2.464Citations (PDF)
128Title is missing!
Virology Journal, 2005, 2, 65
3.610Citations (PDF)
129Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
Virology Journal, 2005, 2,
3.671Citations (PDF)
130Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
Virology, 2004, 329, 11-17
2.3170Citations (PDF)
131Linking chronic wasting disease to scrapie by comparison of Spiroplasma mirum ribosomal DNA sequences2.741Citations (PDF)
132Title is missing!
2004, 1, 10
104Citations (PDF)
133Inhibition of Hepatitis C Virus Nonstructural Protein, Helicase Activity, and Viral Replication by a Recombinant Human Antibody Clone
American Journal of Pathology, 2004, 165, 1163-1173
3.424Citations (PDF)
134Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies
Journal of Clinical Virology, 2004, 31, 190-197
3.011Citations (PDF)
135Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies3.00Citations (PDF)
136Stem-loop structures II-IV of the 5? untranslated sequences are required for the expression of the full-length hepatitis C virus genome
Archives of Virology, 2003, 148, 449-467
1.812Citations (PDF)
137Expression of granzyme B mRNA is altered in human immunodeficiency virus infected patients2.72Citations (PDF)
138Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins
Virology, 2003, 307, 255-265
2.3120Citations (PDF)
139Vaccinia virus-induced inhibition of nitric oxide production
Journal of Surgical Research, 2003, 111, 127-135
1.68Citations (PDF)
140Epstein–Barr virus and human hepatocellular carcinoma
Cancer Letters, 2003, 192, 49-57
8.624Citations (PDF)
141Antibodies to Squalene in Recipients of Anthrax Vaccine2.749Citations (PDF)
142Transmission of HCV to a chimpanzee using virus particles produced in an RNA-transfected HepG2 cell culture
Journal of Medical Virology, 2001, 65, 276-281
3.718Citations (PDF)
143Hepatitis C Viral Proteins Affect Cell Viability and Membrane Permeability2.719Citations (PDF)
144Hepatitis C Virus Protein Expression Induces Apoptosis in HepG2 Cells
Virology, 2001, 282, 26-37
2.333Citations (PDF)
145Serum antibody testing in patients treated with intraocular silicone oil
Annals of Ophthalmology, 2001, 33, 53-55
0.20Citations (PDF)
146HCV RNA levels in hepatocellular carcinomas and adjacent non-tumorous livers1.621Citations (PDF)
147Antibodies to Squalene in Gulf War Syndrome2.784Citations (PDF)
148Detection of Hepatitis C Virus RNA Sequences in B-Cell Non-Hodgkin Lymphoma0.735Citations (PDF)
149Detection of exogenous and endogenous avian leukosis virus in commercial chicken eggs using reverse transcription and polymerase chain reaction assay
Avian Pathology, 1999, 28, 385-392
2.519Citations (PDF)
150Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1
Peptides, 1999, 20, 1275-1283
2.814Citations (PDF)
151Viral induction, transmission and apoptosis among cells infected by a Human Intracisternal A-type retrovirus
Virus Research, 1999, 61, 19-27
2.612Citations (PDF)
152Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder
Biological Psychiatry, 1999, 45, 704-714
5.447Citations (PDF)
153Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells
Aids, 1999, 13, 1827-1839
2.562Citations (PDF)
154Effect of schistosomiasis and hepatitis on liver disease.0.047Citations (PDF)
155Role of Potassium in Human Immunodeficiency Virus Production and Cytopathic Effects
Virology, 1998, 247, 189-199
2.322Citations (PDF)
156Lupus erythematosus‐like features in patients with cutaneous T‐cell lymphoma2.14Citations (PDF)
157Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders
Lancet, The, 1998, 351, 1620-1624
62.3154Citations (PDF)
158Inhibition of HIV Type 1 Production by Hygromycin B1.412Citations (PDF)
159Reactivity of Sera from Systemic Lupus Erythematosus and Sjögren’s Syndrome Patients with Peptides Derived from Human Immunodeficiency Virus p24 Capsid Antigen
Vaccine Journal, 1998, 5, 181-185
3.040Citations (PDF)
160A Synthetic Peptide Corresponding to the Carboxy Terminus of Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein Induces Alterations in the Ionic Permeability of Xenopus laevis Oocytes1.441Citations (PDF)
161Use of antipolymer antibody assay in recipients of silicone breast implants
Lancet, The, 1997, 349, 449-454
62.354Citations (PDF)
162Interaction of erythropoietin RNA binding protein with erythropoietin RNA requires an association with heat shock protein 70
Kidney International, 1997, 51, 579-584
5.318Citations (PDF)
163Biochemical Characterization of the Reverse Transcriptase of a Human Intracisternal A-Type Particle (HIAP)1.45Citations (PDF)
164Activity of Granzyme A, a Serine Protease in the Killing Granules of Cytotoxic T Lymphocytes, Is Reduced in Cells from HIV-infected Hemophiliacs1.45Citations (PDF)
165Inhibition of Na+K+ATPase Activity in Membranes of Sindbis Virus-Infected Chick Cells
Virology, 1996, 216, 299-308
2.313Citations (PDF)
166Reduction of Human Immunodeficiency Virus Production and Cytopathic Effects by Inhibitors of the Na+/K+/2Cl−Cotransporter
Virology, 1996, 219, 291-294
2.319Citations (PDF)
167Antibodies against Retroviral Proteins and Nuclear Antigens in a Subset of Idiopathic CD4 + T Lymphocytopenia Patients1.415Citations (PDF)
168Sequence Similarities between Latent Membrane Protein LMP-1 of Epstein-Barr Virus, Integral Membrane Protein p12 I of Human T Cell Leukemia/Lymphotropic Virus Type 1, E5 Transformation Protein of Bovine Papillomavirus, and the Transmembrane Proteins of Slowly Transforming Retroviruses1.41Citations (PDF)
169Evidence for a Retro Viral Trigger in Graves' Disease
Autoimmunity, 1995, 20, 135-142
3.130Citations (PDF)
170A General Model for the Surface Glycoproteins of HIV and Other Retroviruses1.4114Citations (PDF)
171Sindbis virus-induced inhibition of protein synthesis is partially reversed by medium containing an elevated potassium concentration
Journal of General Virology, 1994, 75, 411-415
3.328Citations (PDF)
172Sequence Similarities between Retroviral Proteins and Components of the Spliceosome1.49Citations (PDF)
173Viral burden in AIDS
Nature, 1993, 365, 301-302
37.919Citations (PDF)
174Sjögren's syndrome and assays for retroviral proteins: Reply
Arthritis and Rheumatism, 1992, 35, 1405-1405
6.13Citations (PDF)
175Membrane alterations linked to early interactions of HIV with the cell surface
Virology, 1992, 191, 941-946
2.342Citations (PDF)
176Concise Communications
Arthritis and Rheumatism, 1991, 34, 1336-1341
6.150Citations (PDF)
177Detection of p24 in HIV-1 infected cells embedded in LR White and Lowicryl K4M
The Histochemical Journal, 1991, 23, 381-384
0.22Citations (PDF)
178A Structural Correlation Between Lentivirus Transmembrane Proteins and Natural Cytolytic Peptides1.4124Citations (PDF)
179Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides
Aids, 1990, 4, 553-558
2.575Citations (PDF)
180Early case of AIDS in the USA
Nature, 1990, 347, 509-509
37.91Citations (PDF)
181Detection of serum antibodies to retroviral proteins in patients with primary sjögren's syndrome (autoimmune exocrinopathy)
Arthritis and Rheumatism, 1990, 33, 774-781
6.1226Citations (PDF)
182Extensive Antigenic Mimicry by Retrovirus Capsid Proteins1.442Citations (PDF)
183A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.10.6160Citations (PDF)
184HIV Infection in 1968-Reply16.60Citations (PDF)
185The role of monovalent cation transport in Sindbis virus maturation and release
Virology, 1989, 172, 42-50
2.333Citations (PDF)
186Alteration of intracellular monovalent cation concentrations by a poliovirus mutant which encodes a defective 2A protease
Virus Research, 1989, 13, 129-141
2.611Citations (PDF)
187A General Model for the Transmembrane Proteins of HIV and Other Retroviruses1.4442Citations (PDF)
188Autogenous growth factor production by reticuloendotheliosis virus-transformed hematopoietic cells3.01Citations (PDF)
189Cell surface effects of human immunodeficiency virus
Bioscience Reports, 1988, 8, 35-48
3.826Citations (PDF)
190Sindbis virus infection decreases intracellular pH: Alkaline medium inhibits processing of sindbis virus polyproteins
Virology, 1988, 166, 1-9
2.337Citations (PDF)
191Development of immunosupportive drugs for patients with AIDS/ARC1.81Citations (PDF)
192Documentation of an AIDS Virus Infection in the United States in 196816.639Citations (PDF)
193Induction of the stress response: alterations in membrane-associated transport systems and protein modification in heat shocked or Sindbis virus-infected cells
Virus Research, 1987, 8, 245-259
2.67Citations (PDF)
194Sindbis virus infection increases hexose transport in quiescent cells
Virology, 1986, 155, 378-391
2.320Citations (PDF)
195Intracellular K+ and the expression of transformation parameters by chick cells transformed with the Bryan strain of Rous sarcoma virus
Virology, 1986, 150, 439-450
2.38Citations (PDF)
196Cell killing by ultraviolet-inactivated human immunodeficiency virus
Virology, 1986, 154, 395-400
2.359Citations (PDF)
197Alterations in monovalent cation transport in sindbis virus-infected chick cells
Virology, 1984, 132, 118-130
2.352Citations (PDF)
198Induction of stress proteins in Sindbis virus- and vesicular stomatitis virus-infected cells
Virology, 1983, 129, 319-332
2.387Citations (PDF)
199Secretion of a virus-regulated factor by clonal variants of reticuloendotheliosis virus-transformed hematopoietic cells
Virology, 1981, 113, 403-407
2.35Citations (PDF)
200Transformation parameters induced in chick cells by incubation in media of altered NaCl concentration
Virology, 1981, 111, 427-439
2.341Citations (PDF)
201Avian reticuloendotheliosis virus: Identification of the hematopoietic target cell for transformation
Cell, 1981, 25, 421-431
33.7107Citations (PDF)
202Chicken fetal antigens: Role as cell surface receptors for sindbis virus hemagglutinin
Virology, 1980, 106, 183-186
2.312Citations (PDF)
203Differential effects of ouabain on host-and sindbis virus-specified protein synthesis
Virology, 1979, 99, 179-182
2.329Citations (PDF)
204Na+ and K+ concentrations and the regulation of protein synthesis in Sindbis virus-infected chick cells
Virology, 1979, 96, 108-120
2.3141Citations (PDF)
205Na+ and K+ concentrations and the regulation of the interferon system in chick cells
Virology, 1979, 96, 121-128
2.341Citations (PDF)
206Effect of incubation time on the generation of defective-interfering particles during undiluted serial passage of sindbis virus in Aedes albopictus and chick cells
Virology, 1979, 96, 229-238
2.320Citations (PDF)
207Host Proteins Identified in Extracellular Viral Particles as Targets for Broad-Spectrum Antiviral Inhibitors3.412Citations (PDF)
208SARS-CoV-2 Spike displays multiple adaptive changes in addition to the furin cleavage site
Virology, 0, 614, 110720
2.30Citations (PDF)
209Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study
Lancet Microbe, The, 0, 6, 101188
12.30Citations (PDF)